232 related articles for article (PubMed ID: 35079804)
21. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
22. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
[TBL] [Abstract][Full Text] [Related]
23. Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome.
Klimova EM; Bozhkov AI; Lavinska OV; Drozdova LA; Kurhuzova NI
Immunobiology; 2023 Jan; 228(1):152316. PubMed ID: 36565610
[TBL] [Abstract][Full Text] [Related]
24. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
[TBL] [Abstract][Full Text] [Related]
25. Immunologic phenotype of patients with long-COVID syndrome of 1-year duration.
García-Abellán J; Fernández M; Padilla S; García JA; Agulló V; Lozano V; Ena N; García-Sánchez L; Gutiérrez F; Masiá M
Front Immunol; 2022; 13():920627. PubMed ID: 36090973
[TBL] [Abstract][Full Text] [Related]
26. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
[TBL] [Abstract][Full Text] [Related]
27. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
28. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Yao Z; Zheng Z; Wu K; Junhua Z
Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
[TBL] [Abstract][Full Text] [Related]
29. Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study.
Torres-Ruiz J; Lomelín-Gascón J; Lira Luna J; Vargas-Castro AS; Pérez-Fragoso A; Nuñez-Aguirre M; Alcalá-Carmona B; Absalón-Aguilar A; Balderas-Miranda JT; Maravillas-Montero JL; Mejía-Domínguez NR; Núñez-Álvarez C; Llorente L; Romero-Ramírez S; Sosa-Hernández VA; Cervantes-Díaz R; Juárez-Vega G; Meza-Sánchez D; Rull-Gabayet M; Martínez-Juárez LA; Morales L; López-López LN; Negrete-Trujillo JA; Falcón-Lezama JA; Valdez-Vázquez RR; Gallardo-Rincón H; Tapia-Conyer R; Gómez-Martín D
Infect Dis (Lond); 2023 Apr; 55(4):243-254. PubMed ID: 36637466
[TBL] [Abstract][Full Text] [Related]
30. Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells in Whole Blood.
Törnell A; Grauers Wiktorin H; Ringlander J; Arabpour M; Nilsson MR; Nilsson S; Kiffin R; Lindh M; Lagging M; Hellstrand K; Martner A
J Infect Dis; 2022 Aug; 226(2):208-216. PubMed ID: 35022764
[TBL] [Abstract][Full Text] [Related]
31. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
32. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study.
Bellan M; Apostolo D; Albè A; Crevola M; Errica N; Ratano G; Tonello S; Minisini R; D'Onghia D; Baricich A; Patrucco F; Zeppegno P; Gramaglia C; Balbo PE; Cappellano G; Casella S; Chiocchetti A; Clivati E; Giordano M; Manfredi M; Patti G; Pinato DJ; Puricelli C; Raineri D; Rolla R; Sainaghi PP; Pirisi M;
Front Immunol; 2022; 13():1038227. PubMed ID: 36601115
[TBL] [Abstract][Full Text] [Related]
33. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.
Patterson BK; Guevara-Coto J; Yogendra R; Francisco EB; Long E; Pise A; Rodrigues H; Parikh P; Mora J; Mora-Rodríguez RA
Front Immunol; 2021; 12():700782. PubMed ID: 34262570
[TBL] [Abstract][Full Text] [Related]
34. Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.
Peluso MJ; Mitchell A; Wang CY; Takahashi S; Hoh R; Tai V; Durstenfeld MS; Hsue PY; Kelly JD; Martin JN; Wilson MR; Greenhouse B; Deeks SG; DeRisi JL; Henrich TJ
J Infect Dis; 2023 Jan; 227(2):246-250. PubMed ID: 36089700
[TBL] [Abstract][Full Text] [Related]
35. Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study.
Torres-Ruiz J; Lomelín-Gascón J; Vargas-Castro AS; Lira-Luna J; Pérez-Fragoso A; Tapia-Conyer R; Nuñez-Aguirre M; Alcalá-Carmona B; Absalón-Aguilar A; Maravillas-Montero JL; Mejía-Domínguez NR; Núñez-Álvarez C; Rull-Gabayet M; Llorente L; Romero-Ramírez S; Sosa-Hernández VA; Cervantes-Díaz R; Juárez-Vega G; Meza-Sánchez DE; Martínez-Juárez LA; Morales-Juárez L; López-López LN; Negrete-Trujillo JA; Falcón-Lezama JA; Valdez-Vázquez RR; Gallardo-Rincón H; Gómez-Martín D
Front Immunol; 2022; 13():943563. PubMed ID: 36045688
[TBL] [Abstract][Full Text] [Related]
36. Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Santopaolo M; Gregorova M; Hamilton F; Arnold D; Long A; Lacey A; Oliver E; Halliday A; Baum H; Hamilton K; Milligan R; Pearce O; Knezevic L; Morales Aza B; Milne A; Milodowski E; Jones E; Lazarus R; Goenka A; Finn A; Maskell N; Davidson AD; Gillespie K; Wooldridge L; Rivino L
Elife; 2023 Jun; 12():. PubMed ID: 37310006
[TBL] [Abstract][Full Text] [Related]
37. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
[TBL] [Abstract][Full Text] [Related]
39. The role of immune activation and antigen persistence in acute and long COVID.
Opsteen S; Files JK; Fram T; Erdmann N
J Investig Med; 2023 Jun; 71(5):545-562. PubMed ID: 36879504
[TBL] [Abstract][Full Text] [Related]
40. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome.
Buonsenso D; Piazza M; Boner AL; Bellanti JA
Allergy Asthma Proc; 2022 May; 43(3):187-193. PubMed ID: 35524358
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
